Association between Immune Checkpoint Inhibitor Treatment Outcomes and Body Composition Factors in Metastatic Renal Cell Carcinoma Patients.
Kohei TakeiToshiki KijimaNaoya OkuboRyo KurashinaHidetoshi KokubunToshitaka UematsuHironori BetsunohMasahiro YashiTakao KamaiPublished in: Cancers (2023)
Sarcopenia was associated with a lower response and shorter survival rates in patients with mRCC who received first-line ICI-based therapy.